These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25772509)

  • 61. Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and δ opioid systems.
    Blume LC; Bass CE; Childers SR; Dalton GD; Roberts DC; Richardson JM; Xiao R; Selley DE; Howlett AC
    J Neurochem; 2013 Mar; 124(6):808-20. PubMed ID: 23286559
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ethanol exposure induces neonatal neurodegeneration by enhancing CB1R Exon1 histone H4K8 acetylation and up-regulating CB1R function causing neurobehavioral abnormalities in adult mice.
    Subbanna S; Nagre NN; Umapathy NS; Pace BS; Basavarajappa BS
    Int J Neuropsychopharmacol; 2014 Oct; 18(5):. PubMed ID: 25609594
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Endocannabinoid receptor deficiency affects maternal care and alters the dam's hippocampal oxytocin receptor and brain-derived neurotrophic factor expression.
    Schechter M; Weller A; Pittel Z; Gross M; Zimmer A; Pinhasov A
    J Neuroendocrinol; 2013 Oct; 25(10):898-909. PubMed ID: 23895426
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Roles of cannabinoid receptors type 1 and 2 on the retinal function of adult mice.
    Cécyre B; Zabouri N; Huppé-Gourgues F; Bouchard JF; Casanova C
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8079-90. PubMed ID: 24255040
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors.
    Irie T; Kikura-Hanajiri R; Usami M; Uchiyama N; Goda Y; Sekino Y
    Neuropharmacology; 2015 Aug; 95():479-91. PubMed ID: 25747605
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interaction between hippocampal serotonin and cannabinoid systems in reactivity to spatial and object novelty detection.
    Nasehi M; Rostam-Nezhad E; Ebrahimi-Ghiri M; Zarrindast MR
    Behav Brain Res; 2017 Jan; 317():272-278. PubMed ID: 27686024
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cannabinoid receptors 1 and 2 oppositely regulate epidermal permeability barrier status and differentiation.
    Roelandt T; Heughebaert C; Bredif S; Giddelo C; Baudouin C; Msika P; Roseeuw D; Uchida Y; Elias PM; Hachem JP
    Exp Dermatol; 2012 Sep; 21(9):688-93. PubMed ID: 22897575
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neurophysiological evidence for the presence of cannabinoid CB1 receptors in the laterodorsal tegmental nucleus.
    Soni N; Satpathy S; Kohlmeier KA
    Eur J Neurosci; 2014 Dec; 40(11):3635-52. PubMed ID: 25251035
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission.
    Kim J; Li Y
    J Physiol; 2015 Feb; 593(4):871-86. PubMed ID: 25504573
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acute activation of CB1 cannabinoid receptors transiently decreases PSA-NCAM expression in the dentate gyrus of the rat hippocampus.
    Maćkowiak M; Chocyk A; Markowicz-Kula K; Wedzony K
    Brain Res; 2007 May; 1148():43-52. PubMed ID: 17355876
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: implications for Huntington's disease.
    Laprairie RB; Kelly ME; Denovan-Wright EM
    Neuropharmacology; 2013 Sep; 72():47-57. PubMed ID: 23602984
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differential Expression of CB
    Kozakiewicz ML; Zhang J; Leone-Kabler S; Yamaleyeva LM; McDonald AG; Brost BC; Howlett AC
    Cannabis Cannabinoid Res; 2022 Jun; 7(3):279-288. PubMed ID: 33998898
    [No Abstract]   [Full Text] [Related]  

  • 73. Neuronal and astrocytic CB1R signaling differentially modulates goal-directed behavior and working memory by distinct temporal mechanisms.
    Shang H; Li P; Lin X; Cai Q; Li Z; Deng L; Song Y; Chen JF; Zhou J
    Neuropsychopharmacology; 2023 Sep; 48(10):1520-1531. PubMed ID: 36694040
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Neuronal and synaptic morphological alterations in the hippocampus of cannabinoid receptor type 1 knockout mice.
    Soriano D; Vacotto M; Brusco A; Caltana L
    J Neurosci Res; 2020 Nov; 98(11):2245-2262. PubMed ID: 32729959
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The C-terminal helix 9 motif in rat cannabinoid receptor type 1 regulates axonal trafficking and surface expression.
    Fletcher-Jones A; Hildick KL; Evans AJ; Nakamura Y; Wilkinson KA; Henley JM
    Elife; 2019 Apr; 8():. PubMed ID: 31036155
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions through conditional genetic rescue in forebrain GABAergic neurons.
    Remmers F; Lange MD; Hamann M; Ruehle S; Pape HC; Lutz B
    Brain Struct Funct; 2017 Nov; 222(8):3431-3452. PubMed ID: 28393261
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hippocampal CB
    Busquets-Garcia A; Oliveira da Cruz JF; Terral G; Pagano Zottola AC; Soria-Gómez E; Contini A; Martin H; Redon B; Varilh M; Ioannidou C; Drago F; Massa F; Fioramonti X; Trifilieff P; Ferreira G; Marsicano G
    Neuron; 2018 Sep; 99(6):1247-1259.e7. PubMed ID: 30174119
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synthetic cannabinoid AM2201 induces seizures: Involvement of cannabinoid CB
    Funada M; Takebayashi-Ohsawa M
    Toxicol Appl Pharmacol; 2018 Jan; 338():1-8. PubMed ID: 29042214
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of novel mouse and rat CB1R isoforms and in silico modeling of human CB1R for peripheral cannabinoid therapeutics.
    Liu QR; Huang NS; Qu H; O'Connell JF; Gonzalez-Mariscal I; Santa-Cruz-Calvo S; Doyle ME; Xi ZX; Wang Y; Onaivi ES; Egan JM
    Acta Pharmacol Sin; 2019 Mar; 40(3):387-397. PubMed ID: 30202012
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor.
    Laprairie RB; Kulkarni PM; Deschamps JR; Kelly MEM; Janero DR; Cascio MG; Stevenson LA; Pertwee RG; Kenakin TP; Denovan-Wright EM; Thakur GA
    ACS Chem Neurosci; 2017 Jun; 8(6):1188-1203. PubMed ID: 28103441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.